Abnova Taiwan Corp

TW:4133 Taiwan Biotechnology
Market Cap
$42.46 Million
NT$1.40 Billion TWD
Market Cap Rank
#23146 Global
#1364 in Taiwan
Share Price
NT$23.20
Change (1 day)
+0.22%
52-Week Range
NT$21.90 - NT$33.90
All Time High
NT$149.53
About

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag… Read more

Abnova Taiwan Corp - Asset Resilience Ratio

Latest as of September 2025: 0.07%

Abnova Taiwan Corp (4133) has an Asset Resilience Ratio of 0.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$878.00K
Cash + Short-term Investments
Total Assets
NT$1.32 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2022)

This chart shows how Abnova Taiwan Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Abnova Taiwan Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$878.00K 0.07%
Total Liquid Assets NT$878.00K 0.07%

Asset Resilience Insights

  • Limited Liquidity: Abnova Taiwan Corp maintains only 0.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Abnova Taiwan Corp Industry Peers by Asset Resilience Ratio

Compare Abnova Taiwan Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Abnova Taiwan Corp (2008–2022)

The table below shows the annual Asset Resilience Ratio data for Abnova Taiwan Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.06% NT$849.00K NT$1.37 Billion +0.02pp
2021-12-31 0.04% NT$545.00K NT$1.28 Billion +0.00pp
2020-12-31 0.04% NT$543.00K NT$1.29 Billion 0.00pp
2019-12-31 0.04% NT$540.00K NT$1.26 Billion +0.00pp
2018-12-31 0.04% NT$537.00K NT$1.29 Billion +0.00pp
2017-12-31 0.04% NT$533.00K NT$1.30 Billion -5.50pp
2016-12-31 5.54% NT$69.11 Million NT$1.25 Billion -10.15pp
2015-12-31 15.69% NT$195.97 Million NT$1.25 Billion +15.65pp
2014-12-31 0.04% NT$522.00K NT$1.31 Billion 0.00pp
2013-12-31 0.04% NT$517.00K NT$1.29 Billion +0.00pp
2012-12-31 0.04% NT$513.00K NT$1.29 Billion +0.00pp
2011-12-31 0.04% NT$508.00K NT$1.36 Billion 0.00pp
2010-12-31 0.04% NT$504.00K NT$1.33 Billion -1.09pp
2009-12-31 1.13% NT$14.72 Million NT$1.31 Billion -0.07pp
2008-12-31 1.20% NT$10.26 Million NT$857.02 Million --
pp = percentage points